stopping

The Hidden Risks of Stopping GLP-1 Medications for Cardiovascular Health

The meteoric rise of glucagon-like peptide-1 (GLP-1) receptor agonists—a class of drugs that includes semaglutide (marketed as Ozempic and Wegovy)…